Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Biomedical Sciences Instrumentation
|
May 12, 2001
Thermistor-based breathing sensor for circadian rhythm evaluation
E Jovanov, D Raskovic, R Hormigo
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 21, 2011
Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluation
L Colonna, V Pacifico, S Lello, et al.
Biomedical Sciences Instrumentation
|
May 12, 2001
Patient monitoring using personal area networks of wireless intelligent sensors
E Jovanov, D Raskovic, J Price, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
April 16, 2010
Efficacy and safety of biologicals against immune-mediated diseases: do benefits outweigh risks?
Liudmika Korkina, P Trakhtman, C De Luca, et al.
Indian Journal of Experimental Biology
|
October 9, 2010
Idiopathic environmental intolerances (IEI): from molecular epidemiology to molecular medicine
C De Luca, G Scordo, E Cesareo, et al.
The British Journal of Dermatology
|
June 21, 2008
Identification of categories at risk for high quality of life impairment in patients with vitiligo
F Sampogna, D Raskovic, L Guerra, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
November 27, 2009
Excimer laser ablation in the treatment of total chronic obstructions in critical limb ischaemia in diabetic patients. Sustained efficacy of plaque recanalisation in mid-term results
F Serino, Y Cao, C Renzi, et al.
Minerva Ginecologica
|
June 13, 2008
[Effect on skin and hormonal hyperandrogenic manifestations of an oral estroprogestin association containing ethynilestradiol 30 mg and drospirenone 3 mg]
S Lello, G Primavera, L Colonna, et al.
Minerva Ginecologica
|
November 17, 2010
[Short-term effect of an estroprogestin containing ethinylestradiol 20 mcg + drospirenone 3 mg in 24+4 regimen at hormonal and cutaneous level in ovarian hyperandrogenism]
S Lello, V Pacifico, G Primavera, et al.
The British Journal of Dermatology
|
April 22, 2004
Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis
L Guerra, G Primavera, D Raskovic, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Biomedical Sciences Instrumentation
|
May 12, 2001
Thermistor-based breathing sensor for circadian rhythm evaluation
E Jovanov, D Raskovic, R Hormigo
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 21, 2011
Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluation
L Colonna, V Pacifico, S Lello, et al.
Biomedical Sciences Instrumentation
|
May 12, 2001
Patient monitoring using personal area networks of wireless intelligent sensors
E Jovanov, D Raskovic, J Price, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
April 16, 2010
Efficacy and safety of biologicals against immune-mediated diseases: do benefits outweigh risks?
Liudmika Korkina, P Trakhtman, C De Luca, et al.
Indian Journal of Experimental Biology
|
October 9, 2010
Idiopathic environmental intolerances (IEI): from molecular epidemiology to molecular medicine
C De Luca, G Scordo, E Cesareo, et al.
The British Journal of Dermatology
|
June 21, 2008
Identification of categories at risk for high quality of life impairment in patients with vitiligo
F Sampogna, D Raskovic, L Guerra, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
November 27, 2009
Excimer laser ablation in the treatment of total chronic obstructions in critical limb ischaemia in diabetic patients. Sustained efficacy of plaque recanalisation in mid-term results
F Serino, Y Cao, C Renzi, et al.
Minerva Ginecologica
|
June 13, 2008
[Effect on skin and hormonal hyperandrogenic manifestations of an oral estroprogestin association containing ethynilestradiol 30 mg and drospirenone 3 mg]
S Lello, G Primavera, L Colonna, et al.
Minerva Ginecologica
|
November 17, 2010
[Short-term effect of an estroprogestin containing ethinylestradiol 20 mcg + drospirenone 3 mg in 24+4 regimen at hormonal and cutaneous level in ovarian hyperandrogenism]
S Lello, V Pacifico, G Primavera, et al.
The British Journal of Dermatology
|
April 22, 2004
Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis
L Guerra, G Primavera, D Raskovic, et al.
Page
of 1